China Feihe IPO Valuation: Reasonable Compared to Peers but Cheap Compared to Market Deal Multiples
In our previous two insights on China Feihe’s IPO, we mainly focused on the industry, the company’s business model and its financials. This...
552 Views
China Feihe IPO: Valuation Is Good for You
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
451 Views
Mengniu (2319): Short Term Uncertainty
China Mengniu Dairy Co (2319 HK)submitted a bid to buy Bellamy's Australia (BAL AU) to increase its participation in the infant milk formula market...
474 Views
Developed International Equity Strategy: Favor EAFE over EM
We highlight attractive and actionable themes within developed international markets, including actionable set-ups across among: Non-bank...
416 Views
Global Equity Strategy: Another Test of Support
Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...
383 Views